Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum dentalcorp Holdings Ltd T.DNTL

Alternate Symbol(s):  DNTCF

dentalcorp Holdings Ltd. is a Canada-based consumer healthcare services company and provider of dental services in Canada. The principal activity of the Company, through its subsidiaries, is to provide health care services by acquiring and partnering with dental practices in Canada. It operates a network of over 551 dental practices, delivering patient experiences to over 2.3 million Canadians.... see more

TSX:DNTL - Post Discussion

dentalcorp Holdings Ltd > Desjardins - cantechletter.com
View:
Post by Possibleidiot01 on Oct 20, 2023 10:48am

Desjardins - cantechletter.com

DNTL stock keeps “Buy” rating at Desjardins

Ahead of third quarter results, due early in November, Dejardins analyst Gary Ho has maintained his “Buy” rating on Dentalcorp Holdings (Dentalcorp Stock Quote, Chart, News, Analysts, Financials TSX:DNTL).

 

In a research update to clients October 19, Ho introduced his 2025 forecast for DNTL, while lowering his price target slightly on the stock. The analyst explained his reasoning.

“We are publishing our preview and introducing 2025 forecasts,” he said. “We expect 3Q revenue and SSSG to be at the lower end of guidance, with 2H acquisitions skewed toward 4Q; we maintain our EBITDA margin. We model DNTL self-funding acquisitions going forward; consequently, deleveraging will be primarily driven by EBITDA growth. We trimmed our target to C$11.50 (from C$12.50) on lower multiples given the contraction in peer valuation. Given its attractive valuation (7.2x 4QF EBITDA), we maintain our Buy.”

Ho’s new price target implied a return of 89.1 per cent at the time of publication.

Ho thinks DNTL will post Adjusted EBITDA of $293-million on revenue of $1.6-billion in fiscal 2024. He expects those numbers will improve to EBITDA of $329-million on a topline of $1.7-billion the following year.

As for the upcoming third quarter, Ho says he expects Adjusted EBITDA of $62.3-million on revenue of $341-million, slightly below the street consensus.

 

“We view DNTL as a quality compounder given its (1) proven M&A playbook in a fragmented market; (2) organic growth outlook; (3) compelling financial profile with resilient top-line growth and growing cash flows; and (4) recession-resistant attributes,” the analyst concluded.



Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities